Literature DB >> 17522341

Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome.

Anne Marie-Cardine, Delphine Huet, Nicolas Ortonne, Natacha Remtoula, Sabine Le Gouvello, Martine Bagot, Armand Bensussan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17522341     DOI： 10.1182/blood-2007-02-071993

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

Review 2.  Sézary Syndrome: Clinical and Biological Aspects.

Authors:  Rebecca Kohnken; Stephanie Fabbro; Justin Hastings; Pierluigi Porcu; Anjali Mishra
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

3.  CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome.

Authors:  Nicolas Ortonne; Sabine Le Gouvello; Hicham Mansour; Catherine Poillet; Nadine Martin; Marie-Hélène Delfau-Larue; Karen Leroy; Jean-Pierre Farcet; Martine Bagot; Armand Bensussan
Journal:  J Invest Dermatol       Date:  2007-08-16       Impact factor: 8.551

4.  Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model.

Authors:  Justine Habault; Nicolas Thonnart; Caroline Ram-Wolff; Martine Bagot; Armand Bensussan; Jean-Luc Poyet; Anne Marie-Cardine
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.